On Nov. 30, Teva Pharmaceuticals Industries Ltd. (NYSE:TEVA) provided detailed non-GAAP guidance on each of its lines of business for the first time. It also reiterated 2012 guidance issued on May 24. The company will unveil its strategy at its Dec. 11 investor